AI Health Tools: Reading Performance Evidence as a Governance Artifact
The performance evidence generated by AI health tools is not merely a collection of metrics. It is a critical governance artifact. For governance committees and…
The performance evidence generated by AI health tools is not merely a collection of metrics. It is a critical governance artifact. For governance committees and…
The pathway to FDA clearance for an AI-powered medical device is a well-trodden, if complex, road. Yet, achieving regulatory approval for the device itself does…
A clearance decision for an AI-powered medical device is a significant milestone, but it is not the finish line. For compliance and quality leads, it…
Companies working through the complex field of AI in healthcare face a critical juncture: either establish a clear, FDA-compliant Software as a Medical Device (SaMD)…
Stop SaMD misinformation. Learn FDA 510(k) timelines, pre-submission tips, and QMS needs to avoid 2026's financial penalties and product recalls.
Boost patient satisfaction by 25% and reduce no-shows. See how digital pathway explainers improve patient adherence and search visibility.
Avoid 30% more FDA enforcement actions and health plan denials. Learn SaMD compliance, QMS, and Pre-Sub to cut 9 months from clearance.
Hello Heart shows how SaMD delivers personalized insights for chronic disease management without replacing clinicians. Learn how FDA rules protect patients.
Understand the FDA SaMD framework's PCCP and why it's critical for AI health tools. Learn to ensure market entry and innovation by 2026.
Stop FDA SaMD AI missteps. Learn why pre-market clearance is often needed and how early FDA engagement via Q-Submission saves time.